Latest | F'cast | |
---|---|---|
Div Yield | 0.7% | |
Div Cover | 4.0 | |
Op Mrgn | 23.6% | |
ROCE | 33.1% |
Latest | F'cast | |
---|---|---|
P/E | 37.1 | |
PEG | 0.2 | |
Pr/Revenue | 7.1 | |
Pr/Book | 3.9 |
Latest | F'cast | |
---|---|---|
Revenue | 15.3% | |
PBT | 163.7% | |
EPS | 209.9% | |
DPS | 2.2% |
Year Ending | Revenue ( m) | Pre-tax ( m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | 5,052.00 | 880.00 | 387.00¢ | 21.8 | n/a | -8% | 127.00¢ | 1.5% |
31-Dec-21 | 5,777.00 | 1,226.00 | 560.00¢ | 17.9 | 0.4 | +45% | 130.00¢ | 1.3% |
31-Dec-22 | 5,517.00 | 511.00 | 221.00¢ | 33.3 | n/a | -60% | 133.00¢ | 1.8% |
31-Dec-23 | 4,867.00 | 441.00 | 181.00¢ | 43.6 | n/a | -18% | 136.00¢ | 1.7% |
31-Dec-24 | 5,613.00 | 1,163.00 | 561.00¢ | 34.3 | 0.2 | +210% | 139.00¢ | 0.7% |
Year Ending | Revenue ( m) | Pre-tax ( m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 6,989.72 | 1,500.05 | 743.10¢ | 28.0 | 0.9 | +32% | 141.88¢ | 0.0% |
31-Dec-26 | 7,930.11 | 2,074.67 | 966.09¢ | 21.6 | 0.7 | +30% | 145.96¢ | 0.0% |
31-Dec-27 | 8,977.44 | 2,800.55 | 1,229.91¢ | 16.9 | 0.6 | +27% | 149.14¢ | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Belgium's UCB to buy US-based Ra Pharmaceuticals... | 10-Oct-2019 | ShareCast |
GSK gets emerging markets boost with UCB deal | 24-Jan-2009 | Telegraph |
UCB confident on drug go-ahead | 21-Aug-2007 | The Scotsman |
Fellner shuffles Acambis board | 08-Mar-2007 | Telegraph |
Currency | Euro |
Share Price | 209.04 |
Change Today | 0.64 |
% Change | 0.31 % |
52 Week High | 210.50 |
52 Week Low | 129.35 |
Volume | 7,060 |
Shares Issued | 190.00m |
Market Cap | 39,718m |
Beta | 1.61 |
Strong Buy | 7 |
Buy | 11 |
Neutral | 3 |
Sell | 0 |
Strong Sell | 0 |
Total | 21 |
Time | Volume / Share Price |
11:10 | 7 @ 209.10 |
11:10 | 13 @ 209.10 |
11:00 | 1 @ 209.00 |
10:58 | 14 @ 209.10 |
10:58 | 49 @ 209.00 |
You are here: research